Stay updated on Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial page.

Latest updates to the Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial page
- ChecktodayChange DetectedAdded Contacts/Locations and Study Status in the study history with Revision: v3.5.0 on 2026-03-19, superseding Revision: v3.4.3.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page history. The new revision identifier is now visible.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedVersion 3.4.2 was added on 2026-02-06, introducing IPD Sharing, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Study Status, and Study Identification; the prior 3.4.1 revision was deleted on 2025-12-03.SummaryDifference1.0%

- Check43 days agoChange DetectedA new Revision: v3.4.1 entry was added to the history and the previous Revision: v3.4.0 entry was removed, reflecting a routine update to the record history.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry v3.3.4 was added and v3.3.3 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry Revision: v3.3.3 is added to the record history; the HHS Vulnerability Disclosure entry and Revision: v3.3.2 are removed.SummaryDifference0.2%

Stay in the know with updates to Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial page.